InvestDashboard.com



Galectin Therapeutics, Inc. (GALT)



$0.49
52 Week Low
$3.06
2017-04-28 14:17:17 MDT
$3.68
52 Week High

Basic Info

Healthcare
Sector
Drugs - Generic
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $109,010,000Micro Cap (Less than $200M)
Analyst Recommendation:3Analysts say: Neutral. (1=Strong Buy, 5=Strong Sell)
Beta: 3.53 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: 28.57%
% Above 200 DayMA: 120.14%
GALT Performance 52 Weeks: 107.79%
S&P 500 Performance 52 Weeks: 13.50%
Uptrend is still intact: GALT is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low.
GALT outperforming S&P 500 by 94.29% the last 52 Weeks.

Profile


More Valuation

Price To Book: 33.23
Not so great value. Low Price to Book means better value. A P/B value of 5 or less is great. But consider other metrics and maybe the growth and yield makes it worth it.
EV to EBITDA: -4.19
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders21.14% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions14.90% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float4.87% 07.02% Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock?
Debt to EquityN/A 1.08Unknown.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %N/A-05.28%Unknown.
Return on Equity %-115.67%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-63.62%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 6.80 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Stock is Above Short Term 50DMA: 28.57%

  2. Stock is Above Long Term 200DMA: 120.14%

  3. Stock outperforming S&P 500 over last 52 weeks: 94.29%

  4. Shorted less than average: 4.87%

CONS:
  1. Price to Cash Ratio (6.80) is greater than average. Company has less cash as a percent of price than the average.

  2. Price to Book is over 10: 33.23

  3. Return on Equity is negative: -115.67%

  4. Return on Assets is negative: -63.62%


Headlines


Stock Chart


InvestDashboard.com GALT: Galectin Therapeutics, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.